Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06330233
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-02
First Post:
2024-03-13
Brief Title:
Different Amounts of Moxibustion in the Treatment of DPN A Clinical RCT Study
Sponsor:
Zhejiang Chinese Medical University
Organization:
Zhejiang Chinese Medical University
Study Overview
Official Title:
Construction of Key Technology and Study of the Effect Mechanism of Moxibustion in the Treatment of Diabetic Peripheral Neuropathy Based on Optimal Selection of Acupoints and Moxibustion Volume
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to provide moxibustion treatment for diabetic peripheral neuropathy DPN and to provide a reference for clinical treatment of DPN moxibustion The first part patients will be randomly assigned to 3 clinical centers 18 in each center and then equally divided into 2 groups including routine treatment group and 15-minute moxibustion group Patients in the routine treatment group were given mecobalamin tablets and epastat at the same time of daily treatment for 4 weeks hypertension and hyperlipidemia combined with basic drug treatment The frequency of moxibustion was 15 minutes per acupoint twice a week for four weeks The results were evaluated during the baseline period the day before the grouping the treatment period the end of the 8th treatment and the follow-up period 2 weeks after the end of treatment The results of this part are expected to confirm the therapeutic effect of moxibustion on diabetic peripheral neuropathy The second part was divided into the moxibustion 15-minute group and the moxibustion 30-minute group 75 cases in each group and 50 cases needed to be assigned to each center Except for the different durations of moxibustion the moxibustion treatment methods and acupoints are the same The results of this part are expected to confirm the optimal amount of moxibustion in the treatment of diabetic peripheral neuralgia and provide a reference for the standardization of clinical treatment of moxibustion
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None